We take companies into Singapore and Southeast Asia, and across the region, through to pilots, partnerships and signed agreements. Not a list of introductions. A few companies at a time, with outcome targets agreed upfront.
Enterprise Singapore GIA cohort, Shanghai and Shenzhen, 17 to 25 February 2025. Co-led by Felicia at XNode. LOIs led to live POCs and signed commercial agreements in the months that followed.
4Singapore startups
78in-market sessions
35qualified leads
14LOIs issued
3converted into live POCs
2converted into commercial agreements
Vision AI
Datature
LOIs with Qidi Digital, Sioux Technologies, UST and ABeam Consulting. Qidi Digital converted into a live POC.
4LOIs
1live POC
Enterprise AI
OneInbox
LOIs with QuickCEP, Qidi Digital, KKH Global, Zhiyuan and UST. QuickCEP went from POC to a signed commercial agreement.
5LOIs
1signed agreement
EdTech devices
myFirst
LOIs with Winnershine, AI iPal and Witi Sports for co-development. A POC that became a commercial agreement.
3LOIs
1commercial agreement
Eldercare
Glorious
LOIs with Caojing Digital Nomad International Village and a hardware manufacturer, both for eldercare POCs.
2LOIs
2eldercare POCs in scope
MedTech
Digital Life Line
Clinical validation pathways secured with healthcare partners, ahead of commercial roll-out.
What we deliver
Four ways to bring Rete in.
Project-based work, priced on duration, effort and the outcomes agreed. Outcome targets are set upfront and every lead is reported back to you, from introduction to agreement. Length is set by the company and the market, from a two-week in-market programme to months of follow-through.
Strategic Access Sprint™
Prepared decision-maker meetings in a target market, with the organisations that have a real reason to buy.
Per market
Pilot & Partnership Builder™
Structuring and landing pilots, POCs and agreements, and staying in until they convert.
Per project
Delegation Programmes
Short in-market programmes for visiting companies, cohorts and trade delegations.
Per cohort
Investor Engagement
Hands-on fundraising: materials, investor targeting and meetings.
You bring the product. Rete brings the follow-through.
A few companies at a time. We find the five to ten organisations with a real reason to buy, get to the decision-maker, and stay in until there is a pilot, POC or commercial agreement.
01
Diagnose
The offer, the buyer, and whether the market is ready.
02
Target
Organisations with a real reason to buy, and the decision-maker in each.
03
Access
Prepared meetings, in-market or virtual.
04
Convert
Follow-through to pilot, POC, MOU or agreement.
05
Report
Every lead tracked from introduction to agreement.
What people say
Her cross cultural understanding and ability to win trust from govt and industry contacts in those markets are the best I've seen.
Gavin ChuaEmpathy AI (now FrontierMind)
Her network is extensive, but it's her judgment, not just her reach, that made the difference.
Weijie Poh, PhDDigital Life Line
Focus
Sector-agnostic, with deep focus areas.
We bridge Singapore to the region, and markets across the region to each other. Open to companies in any sector with a clear commercial case for the market.
SG
Singapore
Headquarters and home market.
SEA
Southeast Asia
Indonesia, Malaysia, Thailand, Vietnam and the Philippines, including inbound from Korea and China.
KR · CN
North Asia
South Korea and China.
AU
Australia
Inbound and outbound, including Korea–Australia and Australia–Indonesia.
QA
Doha
Also active in Qatar.
BioMedTechAI & SaaSReal estate & the built environmentSustainabilityAny sector with a clear commercial case
Sourcing & distribution
From the meeting table to the shelf.
Rete brings healthcare, beauty and F&B brands from Korea and beyond into Singapore, Southeast Asia, Australia and Doha, whether that means a listing on the shelf, a place in clinics and online channels, or a brand's own stores.
Direct purchase
Trial and pilot orders for channel testing in clinics, pharmacies, retail, e-commerce and pop-ups before scaling volume.
Rete as importer
Sourcing for channel partners
Retailers, distributors, F&B operators and healthcare providers brief us on categories. We source, negotiate and coordinate orders.
Rete as sourcing partner
Shelf and channel entry
Distributor matching, retail and supermarket listings, launch and follow-through for brands entering the region.
Rete as distribution partner
F&B and retail store openings
Local partners, sites and launch support for F&B and retail brands opening their own outlets in the region.
Rete as launch partner
Food & beverageMedical devices & suppliesHealthcare & wellnessBeauty & personal care
Who we work with now. Where our founders have been.
Rete's current programme partners, and the wider network built across our founders' previous engagements.
Current partners
TBZ PartnersKorean accelerator for bio-healthcare and sustainable tech
PEN VenturesGlobal accelerator, Silicon Valley and Seoul
co11ab NovenaBioMedTech incubator founded by NTU, A*STAR and NHG
XNodeShanghai-founded accelerator for China market entry
Pijar FoundationIndonesian non-profit for future talent and sustainability
Australian Medical AngelsAustralian doctors’ angel network investing in medtech
Founders' network
Government & agencies
Enterprise Singapore
A*STAR
National Research Foundation
Temasek Foundation
EDBI
Austrade
Corporates
POSCO
Hanwha
Samyang Chemical
Mitsui & Co.
Indofood
Sinarmas
Healthcare & retail
Guardian
Watsons
Sheng Siong
Genting
Agrocorp
Ecosystem & academia
NUS Enterprise
HealthTEC
SEEDS Capital
Tsinghua University
Zhangjiang Group
A non-exhaustive selection across Rete's and its founders' engagements.
Team
Operators first.
Two founders who have run cross-border programmes and worked on the capital side, backed by a specialist bench across venture capital, education and cross-border commerce.
Felicia Ong
Founder
Led XNode's Singapore office and ran Enterprise Singapore Global Innovation Alliance programmes for 40+ startups a year. Builds market access programmes across Singapore, China and the wider region.
Alvin Ng
Co-Founder
Life sciences PhD and venture investor, formerly Venture Partner at Farquhar VC and corporate development director at Esco Lifesciences. Sits on the board of RMIT’s Activator Capital Fund and judges for MedTech Innovator Asia Pacific.
Specialist bench
Lydia Zheng
Deputy CEO, Global School of Technology and Management
Helped bring GSTM into Singapore and build it from launch, and now serves as its Deputy CEO. A serial entrepreneur who also works with Alibaba, she opens doors to decision-makers and brings partners and delegations into Rete’s network.
Sunny Guo
Managing Director, Fong Capital Partners
Leads fundraising and investment in biomedical and medical devices, with earlier roles at BCG, Shenzhen Investment Holdings, Oriental Fortune Capital and the Shenzhen Angel FOF. Has invested in Intellifusion, Readline and Cellbri Bio, and judges for Maker China and Innovative Nanshan.
Contact
Start a conversation.
Tell us the company, the market and the outcome you need. It takes under a minute, and we will get back to you directly.